DONATEOFFICE OF CEO
Note from CEO
Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC) is one of India’s most respected and comprehensive cancer institution. Established in 1996 by the Indraprastha Cancer Society & Research Centre as a non-profit organization, it was founded on the principle that every patient deserves access to quality cancer care, regardless of their financial status or nationality. The unique strength of RGCIRC lies not only in its clinical expertise but also in the empathetic ecosystem it has cultivated over nearly three decades of service.
RGCIRC has grown to become one of Asia’s largest oncology centers, offering a full range of diagnostic, therapeutic, surgical, and research facilities. With advanced capabilities in medical, surgical, and radiation oncology, along with hematology, bone marrow transplantation, nuclear medicine, and robotic surgery, the institute is equipped to manage even the most complex cancer cases. Technologies such as PET-CT, CyberKnife, linear accelerators, and robotic surgical systems ensure precise and minimally invasive interventions, while high-end molecular laboratories enable early detection and tailored treatments through genetic profiling.
At the core of RGCIRC’s reputation is its team of highly skilled medical professionals, their commitment to personalized care is reflected in the multidisciplinary approach that integrates specialists from various fields to collaboratively design individualized treatment plans. This comprehensive care model addresses not just the medical but also the emotional and psychological needs of patients, supporting them throughout their journey.
Staying true to its non-profit roots, the institute operates with a strong philanthropic mission. Through its dedicated Philanthropy Department, RGCIRC provides free or subsidized care to hundreds of underprivileged patients annually. This support is made possible through contributions from donors, corporate CSR programs, and charitable organizations. The institute also ensures that international patients are treated without any differential pricing, further underlining its commitment to equitable care.
Beyond treatment, RGCIRC plays a crucial role in spreading cancer awareness and promoting early detection through outreach programs, education campaigns, and rural screening initiatives. These efforts are particularly impactful in detecting curable cancers at an early stage, improving long-term survival outcomes.
The institute is also a hub for education and research. It offers postgraduate training, fellowships, and continuous learning programs for healthcare professionals. RGCIRC is actively engaged in clinical trials and collaborative studies aimed at advancing cancer treatment and improving patient outcomes. The Molecular Oncology and Genomics Department supports precision medicine through technologies like next-generation sequencing and biomarker analysis, while the biorepository provides ethically managed biological samples that fuel translational research.
As it completes 27 years of dedicated service, RGCIRC continues to innovate, investing in AI-assisted diagnostics, tele-oncology platforms, and expanded genomic services. Through strategic collaborations with global research institutions, the institute maintains a forward-looking approach, constantly evolving to meet the challenges of modern oncology. More than a medical center, RGCIRC stands as a symbol of hope, care, and scientific progress in the fight against cancer.
